Tripolin A
CAS No. 1148118-92-6
Tripolin A ( —— )
产品货号. M22111 CAS No. 1148118-92-6
Tripolin A 是 Aurora A 激酶的特异性非 ATP 竞争性抑制剂(Aurora A 和 Aurora B 的 IC50 值分别为 1.5 μM 和 7 μM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | ¥7345 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Tripolin A
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Tripolin A 是 Aurora A 激酶的特异性非 ATP 竞争性抑制剂(Aurora A 和 Aurora B 的 IC50 值分别为 1.5 μM 和 7 μM)。
-
产品描述Tripolin A is a specific non-ATP competitive inhibitor of Aurora A kinase(Aurora A and Aurora B with IC50 values of 1.5 μM and 7 μM, respectively)Tripolin A, a non-ATP competitive inhibitor.?Tripolin A reduced the localization of pAurora A on spindle microtubules (MTs), affected centrosome integrity, spindle formation and length, as well as MT dynamics in interphase, consistent with Aurora A inhibition by RNAi or other specific inhibitors, such as MLN8054 or MLN8237.?Interestingly, Tripolin A affected the gradient distribution towards the chromosomes, but not the MT binding of HURP (Hepatoma Up-Regulated Protein), a MT-associated protein (MAP) and substrate of the Aurora A kinase.?Therefore Tripolin A reveals a new way of regulating mitotic MT stabilizers through Aurora A phosphorylation.?
-
体外实验Tripolin A induces mitotic spindle defects and spindle pole abnormalities.
-
体内实验——
-
同义词——
-
通路Cell Cycle/DNA Damage
-
靶点Aurora Kinase
-
受体Aurora A
-
研究领域——
-
适应症——
化学信息
-
CAS Number1148118-92-6
-
分子量253.25
-
分子式C15H11NO3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOc3cc(/C=C1\c2ccccc2NC1=O)c(O)cc3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Iliana A Kesisova, et al. Tripolin A, a Novel Small-Molecule Inhibitor of Aurora A Kinase, Reveals New Regulation of HURP's Distribution on Microtubules. PLoS One. 2013;8(3):e58485.
产品手册
关联产品
-
Aurora Kinase Inhibi...
Aurora Kinase Inhibitor II 是一种细胞渗透性苯胺喹唑啉,可抑制 Aurora A 的活性 (IC50 = 0.39 M)。
-
Phthalazinone pyrazo...
Phthalazinonepyrazol 是一种有效的、选择性的、口服生物可利用的 Aurora-A 激酶抑制剂。 Aurora-A 在多种肿瘤类型中过度表达并表现出致癌活性。
-
GSK-1070916
Aurora B 和 C 的有效、选择性和 ATP 竞争性抑制剂,Ki 分别为 0.38 nM 和 1.5 nM。
021-51111890
购物车()
sales@molnova.cn

